Skip to main content
Clinical Trials/NCT00881491
NCT00881491
Completed
Early Phase 1

Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste

The University of Texas Health Science Center at San Antonio1 site in 1 country10 target enrollmentApril 2009

Overview

Phase
Early Phase 1
Intervention
Double Antibiotic Paste
Conditions
Pulp Necrosis
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment
10
Locations
1
Primary Endpoint
The primary outcome measures will be radiographic measurement of root length and dentinal wall thickness.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine the treatment outcomes in permanent teeth with necrotic pulp and immature root development that undergo a regenerative procedure using a triple antibiotic paste (ciprofloxacin, metronidazole, minocycline) versus a double antibiotic paste (ciprofloxacin, metronidazole)compared to the commonly used mineral trioxide aggregate (MTA) apexification treatment.

Detailed Description

Recent case series have reported positive outcomes treating necrotic immature permanent teeth with a regenerative procedure using a triple antibiotic paste (ciprofloxacin, metronidazole, minocycline). However, this method can result in considerable staining due to minocycline. In this randomized clinical trial, we will compare clinical outcomes of a triple antibiotic paste versus a double antibiotic paste (ciprofloxacin, metronidazole) intracanal medicament as compared to a standard treatment (immediate apexification with MTA) in permanent teeth with necrotic pulps and immature root development. We hypothesize there will be no significant differences between radiographic measures of root development after treatment with either the double versus triple antibiotic paste, and that both methods will produce significantly greater increases in root length and width compared to standard treatment. The primary outcome measures will be radiographic measurement of root length and dentinal wall thickness and the secondary outcomes will be lack of clinical symptoms and crown staining.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
January 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kenneth Hargreaves

Chair, Department of Endodontics

The University of Texas Health Science Center at San Antonio

Eligibility Criteria

Inclusion Criteria

  • diagnosis of pulpal necrosis with apical periodontitis
  • patients 7-60 years of age
  • maxillary or mandibular restorable single rooted immature permanent tooth with open apices
  • acceptance of treatment plan with revascularization procedure
  • healthy patient (ASA Class I or II physical status) with no systemic health problems

Exclusion Criteria

  • non-restorable teeth
  • patients with ASA Class III or IV physical status (Immuno-compromised patients including patients who self-report to be a carrier of HIV, undergoing steroid therapy, or those who self-report with genetic or systemic diseases that could result in reduced immune response.
  • child subjects unable to give assent

Arms & Interventions

Group A

Group A - Double antibiotic paste: intracanal medicament consisting of ciprofloxacin and metronidazole

Intervention: Double Antibiotic Paste

Group B

Group B - Triple Antibiotic Paste: intracanal medicament consisting of ciprofloxacin, metronidazole, minocycline

Intervention: Triple Antibiotic Paste

Group C

Group C - Mineral trioxide aggregate: used as an apical barrier

Intervention: Mineral Trioxide Aggregate

Outcomes

Primary Outcomes

The primary outcome measures will be radiographic measurement of root length and dentinal wall thickness.

Time Frame: 3 measurements over 6 months

1. st radiograph taken at 1 month post-procedure completion 2. nd radiograph taken at 3 month post-procedure completion 3. rd radiograph taken at 6 month post-procedure completion

Secondary Outcomes

  • The secondary outcomes will be lack of clinical symptoms and crown staining.(assessed over the 6 month study period)

Study Sites (1)

Loading locations...

Similar Trials